Stockreport

BioXcel launches Phase 2 study of BXCL701 in aggressive type of prostate cancer [Seeking Alpha]

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
PDF BioXcel Therapeutics (BTAI+2.6%Preliminary data should be available in Q4.The company says small molecule BXCL701 is designed to stimulate both the innate and acquired i [Read more]